- 期刊
Current Trends in Targeted Therapies for Glioblastoma Multiforme
被引用紀錄
Chang, M. W. (2014). RGD小分子藥物合併低劑量紫杉醇誘導人類神經膠母細胞瘤凋亡 [doctoral dissertation, National Tsing Hua University]. Airiti Library. https://doi.org/10.6843/NTHU.2014.00625
延伸閱讀
- Perry, J., Okamoto, M., Guiou, M., Shirai, K., Errett, A., & Chakravarti, A. (2012). Novel Therapies in Glioblastoma. Neurology Research International, 2012(), 155-168. https://doi.org/10.1155/2012/428565
- Kalkan, R. (2015). Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma. Clinical Medicine Insights: Oncology, (), 95-103. https://doi.org/10.4137/CMO.S30271
- Chamberlain, M. C. (2011). Bevacizumab for the Treatment of Recurrent Glioblastoma. Clinical Medicine Insights: Oncology, (), 117-129. https://doi.org/10.4137/CMO.S7232
- 王國安（2018）。The Clinical Correlation Between Rac GTPase and Glioblastoma Multiforme〔碩士論文，國立臺灣師範大學〕。華藝線上圖書館。https://doi.org/10.6345/THE.NTNU.SLS.023.2018.D01
- Sungarian, A., Cielo, D., Sampath, P., Bowling, N., Moskal, P., Wands, J. R., & Monte, S. M. D. L. (2009). Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma. Journal of Oncology, 2009(), 79-89. https://doi.org/10.1155/2009/302084